IOB.ch

👏 Warm congratulations from IOB to Katherine A. High, Jean Bennett & Albert Maguire on the 2026 Breakthrough Prize in Life Sciences! Katherine High, CEO of our first spin-off, RhyGaze, brings scientific rigor together with a clear focus on delivering therapies for vision loss to patients. We are pleased to celebrate this well-deserved recognition! 🔗 More details: breakthroughprize.org/Laureates/2/L3…

👁‍🗨We turn science into sight. Congratulations to our Director @IOB_Roska on receiving the 2026 Future Vision Award alongside Connie Cepko & Daniel Ting. A recognition of long-term research now reaching patients. 🎬Watch the short movies: futurevisionfound.org/2026-films #Vision #Retina #Ophthalmology #Blindness #Neuroscience #ScienceInnovation #VisionRestoration #EyeHealth #BiomedicalResearch

The work could help to explain why the risk of developing some brain conditions — such as schizophrenia and Alzheimer’s disease — differs between males and females go.nature.com/486ipEn

Very nice News & Views article on our work by Samantha Krysa and Jonathan Brestoff. @Nature @NaturePortfolio @IOB_ch #MitoCatch #Mitochondria #Neurodegeneration nature.com/articles/d4158…

The mitochondrion-targeting tool MitoCatch brings mitochondria into specific cell types through cell-surface-targeted binders. #NBThighlight nature.com/articles/s4158…

🚀A potential paradigm shift for diseases linked to mitochondrial dysfunction. 📄 Published in @Nature: nature.com/articles/s4158… #MitoCatch #NatureJournal #Mitochondria #PrecisionMedicine #CellTherapy #Neuroscience #VisionResearch #BiotechInnovation #LHON #OpticNeuropathies

✨Key findings: MitoCatch delivers mitochondria to key cell types with higher efficiency. Transferred mitochondria remain functional and targeted cells’ survival is improved.

💡What if we could reboot sick cells? IOB scientists @AyupovTemurkhan, @v_moreno_juan and collaborators led by @IOB_Roska have developed #MitoCatch, a system that delivers healthy mitochondria directly to diseased cells. A step toward precision mitochondrial medicine. 🧵👇

🔬 #MitoCatch uses engineered protein binders, like a cellular GPS, to guide mitochondria exactly where they are needed. Three complementary versions of #MitoCatch enable targeted delivery.

⚡ Mitochondria power our cells. When they fail, diseases like optic nerve degeneration, Parkinson’s, or heart failure can follow. Getting healthy mitochondria to the right cells has been a major challenge.

🌍 This gives researchers worldwide a powerful starting point to develop therapies to preserve vision. #Ophthalmology #OpenScience #VisionResearch #DrugDiscovery #Organoids #Retina

✨The full dataset is openly available, including compounds, targets, and effects. 🔗cell.com/neuron/fulltex…

👁️ What keeps vision cells alive? A new study just published in Neuron (@StefanESpirig, @AlvaroHerrero1 et al.) screened 2,700+ compounds across 20,000 lab grown human retinas to find out. 🧵👇

Potential impact across journalism, law, and science. 📄 Published in Nature Electronics: nature.com/articles/s4192… #Deepfakes #AI #Cybersecurity #DigitalTrust #ETHZurich #Science

🧪Developed by: @FelixFranke7 (IOB), Fernando Cardes García from Andreas Hierlemann’s lab @ETH_en, financially supported by the Swiss National Science Foundation (SNSF) and the State Secretariat for Education, Research and Innovation (SERI) through the SwissChips initiative.

🤖As deepfakes rise, a chip could bring back trust A new sensor technology secures images, videos, and data at capture, making manipulation detectable. 🧵👇